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Abstract  29 
Talaromyces marneffei (T. marneffei) infection causes talaromycosis (previously 30 
known as penicilliosis), the second most-deadly opportunistic systematic mycosis in 31 
immuno-compromised patients. Different virulence mechanisms in T. marneffei had been 32 
proposed and investigated. In the sera of patients with talaromycosis, Mp1 protein (Mp1p), a 33 
secretory galactomannoprotein antigen encoding two tandem ligand-binding domains (Mp1p-34 
LBD1 and Mp1p-LBD2), was found to be abundant. Mp1p-LBD2 was reported to possess a 35 
hydrophobic cavity to bind co-purified palmitic acid (PLM). It was hypothesized that 36 
capturing of lipids from human hosts by expressing large quantity of Mp1p may be a possible 37 
virulence mechanism of T. marneffei. It was shown that expression of Mp1p enhanced the 38 
intracellular survival of T. marneffei by suppressing pro-inflammatory responses. 39 
Mechanistic study of Mp1p-LBD2 suggested that arachidonic acid (AA), precursor of 40 
paracrine signaling molecules for regulations of inflammatory responses, is the major 41 
physiological target of Mp1p-LBD2. In this study, we use crystallographic and biochemical 42 
techniques to further demonstrate that Mp1p-LBD1, the previously unsolved first lipid 43 
binding domain of Mp1p, is also a strong AA-binding domain in Mp1p. These studies on 44 
Mp1p-LBD1 support that the highly-expressed Mp1p is an effective AA-capturing protein. 45 
Each Mp1p can bind up to 4 AA molecules. The crystal structure of Mp1p-LBD1-LBD2 has 46 
also been solved, showing that both LBDs are likely to function independently with a flexible 47 
linker in between. T. marneffei and potentially other pathogens highly expressing and 48 
secreting proteins similar to Mp1p can severely disturb hosts’ signaling cascades during pro-49 
inflammatory responses, by reducing the availabilities of important paracrine signaling 50 
molecules.  51 
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Introduction 52 
Since the first report in 1956, Talaromyces marneffei (T. marneffei, previously known 53 
as Penicillium marneffei) is to-date the only known pathogenic species in Talaromyces genus. 54 
Along with the AIDS outbreak in late 1980’s, talaromycosis caused by T. marneffei was the 55 
second most-deadly opportunistic systemic mycoses, especially in Southeast Asia region 56 
including Northern Thailand, Vietnam, Southern China, Hong Kong and Taiwan (1-4). 57 
Healthy hosts can also be carriers of T. marneffei but the symptoms of talaromycosis develop 58 
only when the immune systems of the hosts are compromised or depressed, for example, in 59 
AIDS patients. The first proposed and characterized virulence mechanism of this pathogenic 60 
fungus is thermal dimorphism, being able to transit from mycelium form (25°C) to yeast 61 
form when its environment reaches host’s body temperature (37°C) (5, 6).  62 
In the sera of talaromycosis-positive patients, a galactomannoprotein antigen MP1 63 
protein (Mp1p) was highly expressed and secreted by the infecting fungus (7). ELISA-based 64 
kit targeting Mp1p was later developed as a diagnostic test (8).  However, it remained 65 
unknown why large quantity of Mp1p was produced at the expense of limited resources for T. 66 
marneffei residing in human hosts. 67 
Mp1p is a 455-residue protein with two tandem domains termed lipid binding 68 
domain-1 and 2 (Mp1p-LBD1 and Mp1p-LBD2, residues 28-180 and residues 188-340, 69 
respectively), followed by a C-terminal Ser/Thr-rich flexible region which is thought to be 70 
the region of O-glycosylations, and a glycophosphatidylinositol-anchor region at the very C-71 
terminus. These two domains share 53% sequence identity and 75% sequence similarity. The 72 
crystal structure of domain-swapped (open conformation) Mp1p-LBD2 complexed with a co-73 
purified palmitic acid (PLM) (16:0), a saturated fatty acid for high-energy storage and other 74 
cellular processes, was reported (PDB 3L1N), first revealing Mp1p-LBD2 is a fatty-acid 75 
binding domain. Mp1p-LBD1 was also described as being unstable in full-length Mp1p and 76 
thus only the structure of Mp1p-LBD2 was reported(9).  77 
Later studies on the infectious and survival behaviors of T. marneffei suggested that 78 
Mp1p is indeed a virulence factor in vivo. Life span of mice model challenged by Mp1-79 
knockout strain of T. marneffei survived up to 60 days without the development of 80 
talaromycosis symptoms, while same challenge with wild-type strain could kill the mice 81 
within 21 days (10). Subsequent pull-down and lipidomic studies on infected macrophages 82 
cell line J774 by T. marneffei showed that arachidonic acid (AA), but not PLM, is the 83 
dominant fatty acid target of Mp1p in vivo. Furthermore, in the same study, it was reported 84 
that the productions of both eicosanoids downstream of AA (e.g. prostaglandin E2) and 85 
common markers of pro-inflammatory responses, including tumor necrosis factor-α and 86 
interleukin-6, were significantly reduced in murine macrophage cell line J774 after T. 87 
marneffei infection. Detailed molecular interaction between captured AAs and Mp1p-LBD2 88 
was characterized by various biophysical methods including X-ray crystallography, nuclear 89 
magnetic resonance (NMR) titration experiment and isothermal titration calorimetry (ITC). 90 
These results together suggested that Mp1p-LBD2, being a strong AA binder, provides a 91 
highly-enclosed central hydrophobic cavity (closed conformation) to accommodate up to two 92 
AA molecules to suppress inflammation, suggesting a new fungal virulence mechanism (11). 93 
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In this study, we focused on the previously uncharacterized LBD1 of Mp1p, Mp1p-94 
LBD1. The crystal structure of Mp1p-LBD1 in complex with co-purified PLM was first 95 
solved, providing the first structural proof that Mp1p-LBD1 is also a fatty acid-binding 96 
domain. Pull-down assay with Mp1p-LBD1 further suggested that, similar to the previously 97 
characterized Mp1p-LBD2, AA is the dominant physiological target of Mp1p-LBD1. Liquid 98 
chromatography–mass spectrometry (LC-MS) quantification on isolated endogenous full-99 
length Mp1p from infected murine macrophage cell line showed that the molar ratio of pull-100 
down full-length Mp1p and bound AA is 1 to 4, thus supporting that both LBDs of Mp1p 101 
bind AA molecules in a full-length Mp1p in vivo. By X-ray crystallography, NMR-titration 102 
experiment and ITC assays, the binding mode of AA molecules in enclosed hydrophobic 103 
cavity of Mp1p-LBD1 was further characterized. A low-resolution crystal structure of Mp1p-104 
LBD1-LBD2 was solved, suggesting the likely independence between the two LBDs in a 105 
full-length Mp1p monomer. The present study thus enhances our understanding on Mp1p, a 106 
novel virulence factor of T. marneffei playing the central role of a novel virulence mechanism 107 
to target and suppress inflammation in hosts. 108 
Results 109 
Mp1p-LBD1 is a fatty acid-binding domain  110 
To begin with our analysis on Mp1p-LBD1, we first purified and crystallized 111 
recombinant Mp1p-LBD1 from E. coli and solved its crystal structure at 1.80Ǻ resolution. 112 
The yield of recombinant protein purified from E. coli source is higher than yeast source, 113 
making it more suitable for both structural and biophysical studies. This domain forms a 114 
complex with co-purified PLM and thus demonstrating that Mp1p-LBD1 also serves as a 115 
fatty acid binding domain (Figure. 1A) like Mp1p-LBD2. However, with one molecule per 116 
asymmetric unit (ASU), the monomeric protein forms a five-helical bundle structure that 117 
resembles Mp1p-LBD2 in complex with AAs (PDB 5CSD), but not the structure of Mp1p-118 
LBD2 in complex with co-purified PLM, which was in an open, domain-swapped form (PDB 119 
3L1N) (Figure.1B). The PLM molecule found in the enclosed central hydrophobic cavity 120 
extends from one end to the other, interacting with various hydrophobic amino acid residues 121 
along the cavity (Figure. 1D). There is an additional hydrogen bond found between the 122 
carboxyl head group of the bound PLM and Gln138 on helix 4. This Gln residue is also 123 
involved in hydrogen bond with singly-bound AA in Mp1p-LBD2 (PDB 5CSD), but not 124 
PLM. Although both Mp1p-LBD1 and Mp1p-LBD2 can bind co-purified PLM, the 125 
orientation preference of the bound PLM is clearly opposite in Mp1p-LBD1 when 126 
superimposed to the structure of Mp1p-LBD2-PLM complex (Figure. 2B). This observation 127 
of Mp1p-LBD1-PLM complex crystallized in a closed conformation instead of an open 128 
conformation as in Mp1p-LBD2-PLM despite the high sequence homology between the two 129 
domains, supports the hypothesis that the occupation of ligand near the N-terminus of helix 3 130 
is correlated to whether Mp1p-LBD prefers an open or closed state in the crystal structure, 131 
but the underlying mechanism of this different preference remains to be elucidated. 132 
 o
n
 M
arch 22, 2019 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
5 
 
 133 
Mp1p-LBD1 can bind up to 2 AA molecules 134 
To elucidate the detailed interaction between Mp1p-LBD1 and its physiological target 135 
AA, the complex structure was solved at 2.60Ǻ resolution. Using purified Mp1p-LBD1 after 136 
delipidation, excess AA was added for crystallization. The individual monomeric structure of 137 
Mp1p-LBD1-AA complex does not differ significantly from the Mp1p-LBD1-PLM complex 138 
or the Mp1p-LBD2-AA complex (Figure. 3A and B). There are ten monomers in an 139 
asymmetric unit. In two of ten monomers, single AA molecules with characteristic U-shaped 140 
conformation can be successfully modeled close to the N-terminal region of helix 3. In 141 
another monomer, two AA molecules are successfully modeled, with one of them showing 142 
conserved U-shaped conformation and overlapping with the position of the AA in 1-AA 143 
bound form, and another AA showing more linear conformation and extending its 144 
unsaturated alkyl chain to the other side of the cavity (Figure. 4A). In similar positions in 145 
other Mp1p-LBD1 monomers, AA models are left unfitted due to the weaker densities 146 
observed.  147 
Superposition of the two AA-bound Mp1p-LBD1 structures to two-AA-bound forms 148 
of Mp1p-LBD2 (PDB 5CSD for 1-AA form and 5FB7 for 2-AAs form, respectively) shows 149 
that there are slight shifts in the positions of the two AAs in Mp1p-LBD1 due to different 150 
hydrogen bond networks involved (Figure. 4B and C). In all solved Mp1p-LBD2 structures, 151 
the singly-bound AA forms hydrogen bond with conserved Gln298 while both AAs in the 2-152 
AA bound state form hydrogen bond network with 3 conserved Ser residues, whereas the 153 
AAs in both 1-AA and 2-AA bound forms of MP1p-LBD1, make hydrogen bonds with non-154 
conserved Asn105 (Ser265 in Mp1p-LBD2 instead) on helix 3 in Mp1p-LBD1.The longer 155 
polar side chain of Asn105 in the central cavity of Mp1p-LBD1 thus provides additional 156 
hydrogen bond interaction absent in Mp1p-LBD2 and thus leads to slight shifts of the 157 
positions of the AAs in the 2-AA bound forms of Mp1p-LBD1  158 
Singly-bound AA in Mp1p-LBD1 interacts via hydrophobic interactions with Phe36, 159 
Leu40, Leu97, Val98, Val101, Val149, Val153 and Leu157 (Left panel, Figure. 3C). The 160 
binding of AAa in the 2-AA bound form also involves same hydrophobic interactions as in 161 
the singly-bound AA, except Phe36. In addition, Ser165 also provides hydrogen bond to 162 
interact with the carboxylic head group of AAa (Middle panel, Figure. 3C). AAb interacts 163 
with the following hydrophobic amino acid residues on the other end of the central cavity: 164 
Val47, Phe50, Ile72, Val104, Ile108, Leu135, Val168 and Leu172 (Right panel, Figure. 3C). 165 
The hydrophobic residues Ile72, Leu97, Val98, Val101, Ile108 and Val149, are involved in 166 
both PLM and AA binding in Mp1p-LBD1.  167 
 168 
Crystal structure of Mp1p-LBD1-LBD2 169 
We successfully crystallized and solved a double-domain structure of Mp1p from 170 
LBD1 to LBD2 as a whole at 4.20Å resolution with 2 molecules per ASU (Figure. 5A). The 171 
structure shows that the two Mp1p-LBD1 domains are both in their closed conformation as in 172 
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the Mp1p-LBD1-PLM/AA structures reported above, flanking the two Mp1p-LBD2 in their 173 
open conformations. This structure is consistent with the individual domain structures of 174 
Mp1p-LBD1 and Mp1p-LBD2 complexed with co-purified PLM.  The densities 175 
corresponding to previously missed linkers between Mp1p-LBD1 and Mp1p-LBD2 in the 176 
monomers were observed in molecular replacement solution and built in this model (Figure. 177 
5C and Supplementary Figure. S1A). Moreover, there are minimal contacts observed 178 
between Mp1p-LBD1 and Mp1p-LBD2 domains within a Mp1p-LBD1-LBD2 monomer and 179 
between two Mp1p-LBD1-LBD2 monomers. These observations suggest that the two Mp1p-180 
LBDs are likely to function independently in the full-length Mp1p. Analytical size exclusion 181 
chromatography coupled to static light scattering (SLS) experiments, on the other hand, 182 
showed that MP1p-LBD1-LBD2 mainly exists as a monomer (expected size: about 35 kDa) 183 
when bound to either co-purified PLM (37 kDa±2.079%) or added AA (34 kDa±2.587%). 184 
 185 
Quantification on pull-down endogenous full-length Mp1p show functional 186 
redundancies of LBDs 187 
Previously, we have shown that endogenous Mp1p could trap AA by co-188 
immunoprecipitation (co-IP) assays and AA could be identified in the lipid extract of 189 
immuno-precipitated products of the T. marneffei-infected cell pellet but not from those of 190 
the non-infected cell samples(11). In the present study, we have performed quantifications of 191 
the pull-down endogenous full-length Mp1p as well as the amount of AA extracted from the 192 
Mp1p IP product. The level of Mp1p IP product was found to be 0.864 ± 0.061 pmol per 193 
1x10
6
 J774 cell pellet and the corresponding amount of AA extracted from the Mp1p IP 194 
product was 3.10 ± 0.06 pmol. By comparison, the amount of AA extracted was about 4 195 
molar equivalents of that of full length Mp1p, which is consistent with the fact that each of 196 
the LBD domains can trap two AA molecules. The present co-IP experiments indicate that in 197 
the endogenous full-length Mp1p, each LBD domain has trapped two molecules of AA, 198 
suggesting that both domains carried equal functionality in terms of their ability of trapping 199 
cellular AA. 200 
 201 
Pull down assay and LC-MS study suggest that AA is a physiological binding target of 202 
Mp1p-LBD1 of T. marneffei Mp1p 203 
 Knowing that Mp1p-LBD1 can indeed bind fatty acids leads to speculation that it may 204 
also serve to bind other important fatty acids when T. marneffei infects host and thus 205 
contributes to interrupting hosts’ lipid metabolism. We have performed in vitro pull-down 206 
experiments on the cell lysate of J774 macrophage cells using recombinant His-tagged 207 
Mp1p-LBD1 protein in order to identify its potential cellular target. Lipopolysaccharides 208 
(LPS) is the standard chemical for inducing the inflammatory responses with up-regulation of 209 
cytokines, the lipid mediators and their metabolites. We have used LPS-activated J774 cells 210 
in our pull-down experiment to better simulate the lipid profile of infected macrophages. In 211 
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order to reveal the dominant higher affinity binding substrates of Mp1p-LBD1, we used 212 
progressively lower amount of Mp1p-LBD1 in a series of pull-down experiments. By 213 
comparing the results, we could then know the identity of substrates which have higher 214 
affinity to Mp1p-LBD1 under the condition of reducing and limited amount of protein. Table 215 
3A lists the identified substrates from the pull-down experiment of Mp1p-LBD1 against the 216 
cell lysate of 3×10
6
 LPS-activated J774 cells. Three sets of experiments using 1000, 250 and 217 
50 µg of bait Mp1p-LBD1 were performed. When 1000 µg bait protein Mp1p-LBD1 was 218 
used, AA, PLM, oleic acid and 4 lysophosphatidylcholines (LPCs) were found in the pull-219 
down profile list. When the amount of bait was reduced 4 times to 250 µg Mp1p-LBD1, AA, 220 
PLM, oleic acid LPC1 and LPC2 were found. When we further reduced the bait amount to 50 221 
µg Mp1p-LBD1, all LPCs and PLM were no longer detectable in the pull-down list. These 222 
results indicate that Mp1p-LBD1 is capable of binding various lipid substrates but AA is the 223 
dominant ligand in vivo even though AA was the least abundant in the pool of cellular lipids 224 
(Supplemental Table S2 in (11)). The identities of AA, PLM and oleic acid in the pull-down 225 
lipid extracts were confirmed by using their pure standards. In negative mode, the peak at m/z 226 
303.2323 and eluted at RT 16.16 min was found to be a significant mass features (MF) in all 227 
three pull-down extraction samples (Supplementary Figure 2A). Waters MassLynx Analysis 228 
software (Version 4.1, Waters, USA) suggested a molecular formula of C20H32O2 which 229 
nicely matched that of AA. Its identity was subsequently confirmed using pure AA standard 230 
which showed a well-matched spectrum. The peak at m/z 285 represented a fragment after 231 
neutral loss of water from AA while the loss of the polar ester group exhibited the peak at 232 
m/z 259. The cleavage of the remaining aliphatic chain contributed to the other fragments 233 
observed in the tandem mass spectrometry (MS/MS) spectrum (Supplementary Figure S2A). 234 
The identities of the observed LPCs were classified to these lipid classes by their MS/MS 235 
fragmentation patterns (Supplementary Figure S2B). The characteristic head group of 236 
phosphatidylcholine, m/z=184.1, was applied for detection of phosphatidylcholines and LPCs 237 
under positive mode. Fatty acid moieties of identified LPCs were determined using fatty acid 238 
scanning (FAS) method as described by Ekroos et al (2003) (12) (Table 3B). According to 239 
their characteristic fragmentation peaks, a series of LPCs were putatively identified in the 240 
pull-down extraction samples of Mp1p-LBD1 against the cell lysate of J774 macrophages 241 
(Table 3A). 242 
  243 
NMR-titration and isothermal titration calorimetry (ITC) of LBD1 with AA molecule 244 
show two-step binding process 245 
We then verified the AA binding property of Mp1p-LBD1 with NMR and ITC. 246 
Figure 7 shows the overlaid 2D 
1
H-
15
N HSQC NMR spectra of delipidated 
15
N-labeled 247 
Mp1p-LBD1 (blue-colored cross-peaks) and delipidated 
15
N-labeled Mp1p-LBD1 after the 248 
addition of 3.0 molar equivalent of AA (red-colored cross-peaks). Large and specific changes 249 
of amide cross peaks upon the addition of AA indicated that Mp1p-LBD1 could bind to AA 250 
and the binding was site-specific. We also carried out isothermal titration calorimetry (ITC) 251 
to characterize the binding of AA to Mp1p-LBD1. Figure 8 shows the ITC raw heats of 252 
binding and isotherms of AA titrated into wild-type Mp1p-LBD1. The isotherm for titration 253 
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of AA into wild-type Mp1p-LBD1 shows a two-step curve and is best fitted with a two-state 254 
model similar to that previously observed in Mp1p-LBD2. Fitting of the ITC isotherm with 255 
two-site model gives the first binding site a high affinity Kd of 24 nM while the second 256 
binding site has a moderate affinity Kd of 2.3 µM.  Compared with Mp1p-LBD2 having 13 257 
nM and 2.3 µM for the first and second AA binding Kd’s (11), respectively, Mp1p-LBD1’s 258 
first AA binding Kd is lower but its second AA binding Kd is similar. Since singly-bound AA 259 
in Mp1p-LBD1 reported here occupies the same position as the first binding site in Mp1p-260 
LBD2 previously solved (Figure. 4B), we further suggest that the site for the U-shaped AA 261 
binding is the high affinity site of Mp1p-LBD1 while the adjacent site for the second linear 262 
AA.  263 
Discussion 264 
Talaromycosis caused by Talaromyces marneffei is currently the second most deadly 265 
opportunistic infection in Southeast Asia, being found mainly in AIDS patients and patients 266 
after receiving organ transplantations. One of the key virulence mechanisms known that 267 
makes T. marneffei exceptionally pathogenic is its thermal dimorphism to transform to yeast 268 
form when in hosts(5, 6). It was later reported that expression of Mp1p also plays an 269 
important role to suppress hosts’ pro-inflammatory responses because its Mp1p-LBD2 can 270 
capture released AA during the onset of pro-inflammatory responses to reduce the production 271 
of downstream eicosanoids(11). In this study, we have further investigated the previously 272 
uncharacterized Mp1p-LBD1 of T. marneffei Mp1p, and revealed that it structurally 273 
resembles Mp1p-LBD2 in terms of folding and strong two AAs binding property. Each Mp1p 274 
thus has two AA-binding domains functioning independently in vivo. Although it is logical 275 
from the structural point of view that Mp1p-LBD1 and Mp1p-LBD2 may function 276 
independently, having two LBD domains with similar biological function may render avidity 277 
for Mp1p. In particularly, this might be important for inhibiting and efficient trapping of a 278 
ligand. Individually, each binding interaction may be readily broken; however, when many 279 
binding interactions are present at the same time, transient unbinding of a single site does not 280 
allow the molecule to diffuse away, and binding of that weak interaction is likely to be 281 
restored. Antibody is a perfect example for avidity because each antibody has at least two 282 
antigen-binding sites, therefore antibodies are bivalent to multivalent. For example, IgM is 283 
said to have low affinity but high avidity because it has 10 weak binding sites for antigen as 284 
opposed to the 2 stronger binding sites of IgG, IgE and IgD with higher single binding 285 
affinities (13) 286 
Despite both Mp1p-LBD1 and Mp1p-LBD2 were first identified as fatty acid-binding 287 
domains by the discovery of singly-bound PLM inside their crystal structures, in vivo lipid 288 
pull-down experiments suggested that both domains bind to AA most specifically when 289 
under actual pathological environment inside the host even though other cellular lipids such 290 
as PLM, oleic acid, phosphatidylcholines and LPC are more abundant than AA. Although we 291 
cannot rule out the possibility that, other endogenous hydrophobic ligands may also pre-292 
occupy the central cavities of the LBDs (for example, PLM). The observation that AA is the 293 
only ligand found in Mp1p secreted by T. marneffei in macrophage cell line (11) supports 294 
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that both the Mp1p-LBD1 and Mp1p-LBD2 domains will soon be occupied by released AA 295 
to displace other occupying lipid molecules, during the early steps of pro-inflammatory 296 
responses.  297 
Our structural and biophysical analysis on both Mp1p-LBDs in the full-length Mp1p 298 
suggested that they are of equal importance in terms of AA capturing and each of them can 299 
accommodate two AA molecules. It remains unclear why duplication of LBD is present in T. 300 
marneffei Mp1p. So far, there is no experimental data on how the full-length Mp1p function 301 
would be disrupted in vivo when AA-binding function of either Mp1p-LBD1 or Mp1p-LBD2 302 
is abolished by mutations. We suggest that one possible advantage of having two functionally 303 
duplicated and independent Mp1p-LBDs in one single protein is to double Mp1p-LBD 304 
production efficiency. Fast production of sufficient amount of LBD in the form of full length 305 
Mp1p is critical for the survival of T. marneffei to effectively reduce the availability of AA 306 
because the onset of pro-inflammatory response happens after detection of invasion. 307 
Concentration of pro-inflammatory eicosanoids in response to T. marneffei infection might 308 
reach a threshold to trigger innate immune responses and eliminate T. marneffei before 309 
sufficient amount of LBD is being secreted and accumulated if the rate of LBD production is 310 
slow.  311 
Our low-resolution crystal structure of Mp1p-LBD1-LBD2 first demonstrates that the 312 
two Mp1p-LBDs are very likely to function independently since the contact between the two 313 
LBD domains is minimal. Moreover, a flexible linker was observed connecting these two 314 
domains in a monomer. As expected, two Mp1p-LBD1 domains in this Mp1p-LBD1-LBD2 315 
dimeric crystal structure remain as closed five-helical bundle exactly the same as single 316 
domain structure complexed with PLM or AA reported in this study. The Mp1p-LBD2 317 
domains adopt a domain-swapped open conformation exactly the same as the Mp1p-LBD2 318 
structure in complex with PLM (9) (PDB 3L1N). Despite parallel SLS measurement showed 319 
that Mp1p-LBD1-LBD2 remains monomeric in solution regardless of bound ligands, this 320 
structure disfavors the explanation that the unusual domain-swapped open conformation of 321 
Mp1p-LBD2 is due to crystallization because the two structures, Mp1p-LBD2-PLM (PDB 322 
3L1N) and Mp1p-LBD1-LBD2 both reported here, were crystallized in different conditions 323 
and space groups, hence different chemical environments for the ASU. Taken together, these 324 
observations suggest a model that Mp1p-LBD2 in full-length Mp1p still adopts an open 325 
conformation when not bound to AA in solution. Once bound to the released AA from host’s 326 
pro-inflammatory responses, Mp1p-LBD2 undergoes conformational changes to adopt a 327 
closed conformation. Mp1p-LBD1 possibly goes through a different mechanism from Mp1p-328 
LBD2 for AA to enter the central cavity as the closed conformation is the only conformation 329 
observed so far. 330 
We have performed ELISA measurements to estimate the level of expression of 331 
Mp1p in infected J774 cell samples. At 48 hours post-infection, the levels of free Mp1p were 332 
found to be 0.864 ± 0.061 pmol in cell pellet, and 0.116 ± 0.003 pmol in culture supernatant 333 
per 1x10
6
 J774 cells, respectively (Supplemental Table S1 in (11)). The free AA 334 
concentration varied from cell types and conditions, e.g. 100 µM (inflamed skin tissue), 13 335 
µM (uninvolved skin) (14), 15 µM (resting islets of Langerhans) (15), 0.5-1 µM (resting 336 
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leukocytes) (16), (17). Our quantitative MS measurements gave total cellular amount of AA 337 
to be 33.0 and 28.2 pmol per pellet of 1x10
6
 J774 cells infected with Mp1p knockout and 338 
wild-type T. marneffei strains, respectively (Table 2). Therefore, the level of free Mp1p is 339 
about 3% that of total cellular AA level. Compared with knockout strain-infected J774 cells, 340 
there is 15% reduction of AA level in J774 cells infected by wild-type T. marneffei. We 341 
believe that this observed level of reduction of AA is reasonable given that each full-length 342 
Mp1p can trap multiple molecules of AA. AA is a key proinflammatory signal mediator 343 
because it generates the downstream eicosanoid family of mediators. These eicosanoids have 344 
potent inflammatory actions, some reaching nanomolar scale, and they can also regulate the 345 
production of other mediators including inflammatory cytokines. Since the biosynthesis of 346 
eicosanoids depends on the availability of free AA, the base level of free AA in resting cells 347 
is under tight control and maintained to be low by locking excess AA into phospholipid pool 348 
in esterified form by the action of coenzyme A synthetase (Brash, 2001). In response to 349 
infection by microbes, phospholipase A2 is activated to hydrolyze the ester bonds in 350 
membrane phospholipids to yield lysophospholipids and AA to initiate the inflammatory 351 
response. This is the first line host innate immune defense again microbe infection. In our 352 
previous study of Mp1p, we have shown that Mp1p was able to sequester AA with 353 
corresponding downstream effects of reducing AA metabolites including PGE2, PGD2, 15-354 
HETE, 11(12)-EET from each of the AA downstream pathways (11). However, no 355 
significant changes of AA levels were observed for J774 cells infected with MP1 knockout 356 
strain of T. marneffei because no Mp1p was expected to be expressed by the MP1 knockout 357 
strain (Table 2). Moreover, we also observed a significant increased production of 358 
interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) for the MP1 knockout strain 359 
infected J774 cells (11). Therefore, our present and previous studies on Mp1p have strongly 360 
supported that the observed trapping of AA by Mp1p have caused a subtle and significance 361 
lowering of cellular AA level with subsequent biological consequences of suppressing 362 
downstream AA metabolites and proinflammatory cytokines IL-6 and TNF-α. 363 
Finally, given that the continuous secretion of Mp1p by T. marneffei is a demanding 364 
task for the pathogen under the limiting environment in the host cell, we believe it is 365 
reasonable that the amount of Mp1p secreted will be limited to maintain a near to  or slightly 366 
lower than base level of cellular AA to evade host innate immune response by dampening the 367 
AA downstream pathway of pro-inflammatory signals.  It is conceivable that Mp1p is 368 
designed to trap more than one AA molecule to increase its trapping efficiency in cells. As 369 
far as we know, all known AA binding fatty acid-binding proteins, cyclooxygenases and 370 
lipoxygenases interact with one molecule of AA per binding site. Physiologically, this ability 371 
to trap more than one AA molecule per Mp1p will improve the efficiency of anti-372 
inflammatory action by Mp1p through encapsulation of AA which will be critical at the 373 
initial stage of the T. marneffei infection. Furthermore, the plasticity of Mp1p to bind one or 374 
more AA molecules with different affinities may reflect the flexibility of this class of AA-375 
binding proteins to sequester AA in response to the abundance of available inflammatory 376 
mediators generated by the host. 377 
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Following a Domain Enhanced Lookup Time Accelerated BLAST (DELTA-BLAST) 378 
search (https://blast.ncbi.nlm.nih.gov/Blast.cgi), many putative Mp1p-LBD1 homologues 379 
could be identified in fungal pathogens, such as  Aspergillus flavus and Aspergillus fumigatus 380 
with sequence identity ranging from 23 % to 44 %. The results after filtering the matches for 381 
T. marneffei are summarized in Supplemental Table S1. We have characterized a number of 382 
these putative Mp1p-like homologues of T. marneffei for serodiagnosis, including Aflmp1 of 383 
A. flavus and Afmp1p and Afmp2p of A. fumigatus (18-24). A. flavus and A. fumigatus are 384 
causing aspergilloma and invasive aspergillosis globally and they are the most prominent 385 
opportunistic fungal pathogens in immunocompromised host. In our on-going investigations 386 
of these Mp1p homologues, we have confirmed that Mp1p homologues Afmp1p, Afmp2p, 387 
Afmp3p and Afmp4p are virulence factors of A. fumigatus(25) and they can all bind AA in a 388 
similar five-helix bundle fold as Mp1p-LBD1 or Mp1p-LBD2 but each only carrying a single 389 
LBD rather two LBDs. Full structural and functional characterizations of the binding of AA 390 
with Afmp1p, Afmp2p and Afmp4p will be described in a forthcoming manuscript. Here, we 391 
showed that these fungi may produce Mp1p or its homologues which could capture AA to 392 
stall the inflammatory process. We are in the process of characterizing other Mp1p 393 
homologues identified in our studies. This novel function of trapping key pro-inflammatory 394 
signaling lipid by “Mp1p-like” virulence factor to evade host innate immunity may be a 395 
widely present virulent mechanism in other fungal pathogens. Mp1p thus represents a novel 396 
class of fatty acid binding proteins with the function of targeting key proinflammatory 397 
signaling lipid to dampen host innate immune response. 398 
 399 
Experimental procedures 400 
Construction of expression plasmids for E. coli expression system 401 
Full length cDNA of T. marneffei Mp1p (strain Mp1) was kindly provided by Prof. 402 
KY Yuen’s group (Department of Microbiology, HKU). The pair of primers used for Mp1p-403 
LBD1 (a.a. 27 to 182 of full-length Mp1) was 404 
CAACAAGGATCCACCAAGGACCAGCGTGATG (Forward) and 405 
CTACTCGAGTTAGCTAATGGAGAAGGCTTCG (Reverse). The pair of primers used for 406 
Mp1p-LBD1-LBD2 (a.a. 27-342 of full-length Mp1) construct was 407 
CAACAAGGATCCACCAAGGACCAGCGTGATG (Forward, same as the forward primer 408 
for subcloning of Mp1p-LBD1) and CAACTCGAGTTAAGTGCCGGCGAAG (Reverse). 409 
PCR experiments were performed on the provided cDNA to subclone the amplified 410 
fragments into an ampicillin-resistant expression vector including N-terminal hexahistidine 411 
tag and SUMO tag (His-SUMO) preceding the target fragments with an Ulp1 cleavage site in 412 
between, using restriction enzymes BamHI and XhoI (NEB). Following standard protocol of 413 
42°C heat shock transformation and selection with 100μg/mL ampicillin, selected colonies 414 
were picked and grown in LB-Broth for plasmids extraction and sequencing (BGI). Correct 415 
plasmids were transformed into E. coli expression strain BL21(DE3) (Invitrogen) to express 416 
the recombinant proteins.  417 
 418 
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Expression and purification of LBD1 and LBD-LBD2 from BL21(DE3) 419 
4L of transformed BL21(DE3) were agitated at 37°C, 230rpm in LB-Broth with 420 
100μg/mL ampicillin until OD600 was between 0.6 and 0.7. 0.5mM isopropyl-beta-D-421 
thiogalactopyranoside (IPTG) was added for induction at 16°C. After 16 hours of induction, 422 
cell pellet was harvested by centrifugation and then was lysed by sonication in lysis buffer 423 
(25mM Tris-HCl (pH 7.5), 500mM NaCl and 10mM imidazole). Further centrifugation was 424 
performed to obtain the supernatant of soluble total protein. Filtered supernatant was slowly 425 
loaded by gravity flow onto 5mL His60 Superflow Ni-IDA resin (Clontech) equilibrated with 426 
lysis buffer. After washing with 25mL lysis buffer and same buffer with 50mM imidazole, 427 
remained bound protein was eluted with step gradient of 250mM and 500mM imidazole. 428 
Fractions containing target SUMO-Mp1p-LBD1 were combined and the His-SUMO tag was 429 
released with Ulp1 with simultaneous overnight dialysis against 3L buffer (25mM Tris-HCl 430 
(pH 7.5), 50mM NaCl) at 4°C. Cleaved protein was slowly reloaded onto 5mL His60 431 
Superflow Ni-IDA resin equilibrated with buffer (25mM Tris-HCl (pH 7.5), 50mM NaCl). 432 
Flow-through containing Mp1p-LBD1 was collected and further purified with 5mL HiTrap
TM
 433 
Q-HP column (GE Healthcare). Target protein was mostly found in the flow-through 434 
(Supplementary Figure.S4) and it was concentrated at 4°C with Amicon
TM
 Ultra unit (3kDa 435 
cut-off) to 40mg/mL with calculated extinction coefficient 2980M
-1
cm
-1
. 436 
SUMO-tagged Mp1p-LBD1-LBD2 was overexpressed in the same way as the 437 
SUMO-tagged Mp1p-LBD1. The pellet of induced cell was lysed by sonication in lysis 438 
buffer (25mM Tris-HCl (pH 8.0), 500mM NaCl and 10mM imidazole). Further 439 
centrifugation was performed to remove cell debris. Filtered supernatant was then slowly 440 
loaded by gravity flow onto 5mL His60 Superflow Ni-IDA resin (Clontech) equilibrated with 441 
lysis buffer. After washing with 25mL lysis buffer and same buffer with 50mM imidazole, 442 
remained protein was eluted with step gradient of 250mM and 500mM imidazole The 443 
fractions containing the expressed protein with tag was then further purified with 5mL 444 
HiTrap
TM
 Q-HP column (GE Healthcare). Protein was eluted in a single peak with linear 445 
NaCl gradient. The His-SUMO-tag was removed with added Ulp1 overnight at 4°C with 446 
slow agitation for thorough mixing. To obtain the target protein without tag, all cleaved 447 
sample was loaded onto 5mL HisTrap
TM
-HP column (GE Healthcare) equilibrated with 448 
buffer (25mM Tris-HCl (pH 8.0), 100mM NaCl). Target protein was found in the flow-449 
through with good purity (Supplementary Figure.S4). It was concentrated at 4°C with 450 
Amicon
TM
 Ultra unit (10kDa cut-off) to 40mg/mL with calculated extinction coefficient 4470 451 
M
-1
cm
-1
. 452 
 453 
Delipidation on purified protein samples and preparation of AA-bound samples 454 
 All recombinant Mp1p constructs from E. coli expression systems are found to 455 
contain endogenous fatty acids. Delipidation protocol used to remove the endogenous fatty 456 
acids was described before on Mp1p-LBD2 (9). Briefly, 5mL of the protein sample was 457 
mixed with 4mL of di-isopropyl ether (DIPE) and n-butanol mixture (3:2 (v/v)). The total 458 
mixture was agitated gently for 30minutes at room temperature to perform the removal of 459 
bound fatty acid and the protein-containing aqueous phase and fatty-acid containing organic 460 
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phase were separated by centrifugation (1000g, 10minutes, 4°C). The upper organic phase 461 
was removed and fresh organic solvent mixture was added again to repeat the extraction 462 
process for at least twice more. 8mL of DIPE was then added to remove the residual n-463 
butanol in aqueous phase. After another centrifugation to separate the two phases, protein 464 
was retrieved by penetrating the bottom of centrifuge tube with a needle and 5mL syringe.  465 
Dialysis against 1L of buffer (25mM Tris-HCl (pH 7.5), 100mM NaCl) overnight at 4°C was 466 
performed on the retrieved protein to further dilute the remaining organic solvent. 467 
Delipidated protein concentrations were determined with the calculated extinction 468 
coefficients and 6:1 molar excess of freshly prepared 100mM AA dissolved in 100mM 469 
NaOH on ice was directly added to the delipidated protein. After incubation for one hour at 470 
4°C, the protein-ligand complexes were concentrated to 40mg/mL and the buffer was 471 
intensively exchanged to the buffers of the untreated proteins, with Amicon
TM
 Ultra unit 472 
(3kDa cut-off).  473 
 474 
Crystallization  475 
The crystals of Mp1p-LBD1 with co-purified PLM (40mg/mL) were grown by 476 
mixing 1μL of protein sample with 1μL reservoir solution (0.1M sodium acetate (pH 4.6), 477 
0.2M ammonium sulphate, 20% PEG12000), using hanging-drop vapour diffusion method at 478 
298K. Fully grown and qualified crystals were observed after one week (Supplementary 479 
Figure.S4). Cryo-protectant was the same reservoir solution with additional 16% glycerol 480 
(v/v). The crystals of Mp1p-LBD1 complexed with AA (40mg/mL) were grown by mixing 481 
1μL of protein sample with 1μL reservoir solution (0.1M sodium acetate (pH 4.6), 0.2M 482 
ammonium acetate, 20% PEG4000), using hanging-drop vapour diffusion method at 298K. 483 
Fully grown and qualified crystals were observed after 4 days of incubation (Supplementary 484 
figure.S4). Cryo-protectant was the same reservoir solution with 16% glycerol (v/v). The 485 
needle crystals of Mp1p-LBD1-LBD2 were obtained from crystallization condition 0.1M 486 
Tris-HCl pH 8.4, 10mM NiCl2, 1.1 M Li2SO4, 5% glycerol (v/v) after two weeks of 487 
incubation using hanging drop method at 298K (Supplementary Figure.S4). The cryo-488 
protectant used was the same as mother liquor with 16% glycerol (v/v). 489 
 490 
Crystallographic data collection, phasing and models refinement  491 
Diffraction data of Mp1p-LBD1-PLM at resolution 1.80Å were collected at beamline 492 
IO2, DIAMOND, Oxford, UK, at 100K. Indexing, integrating and scaling were performed 493 
with the XDS package provided on site (26). Data of Mp1p-LBD1-AA at resolution 2.60Å 494 
were collected at beamline PROXIMA-I, SOLEIL, Paris, France, at 100K. Indexing, 495 
integrating and scaling were performed with HKL2000 package (27). The Mp1p-LBD1-PLM 496 
structure was solved with apo-Mp1p-LBD2 structure as a search model (PDB 5CSD) by 497 
molecular replacement method (MR) using Phaser in CCP4 package (28). The resultant 498 
model of the single solution was then manually mutated to amino acid sequence of Mp1p-499 
LBD1.  Refinement was performed with cycles of manual adjustment of model using Coot 500 
(29) and Refmac5 (30) included in CCP4 package. Water molecules and PLM molecule were 501 
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added and checked manually at last and refined with Refmac5 again to obtain a final model. 502 
The dataset of Mp1p-LBD1-AA was solved with the apo-LBD1 structure as a search model 503 
for molecular replacement using Phaser in CCP4 package. Refinement was performed with 504 
cycles of manual adjustment of model using Coot and Refmac5 also included in CCP4 505 
package. Water molecules and AA molecules were added and checked manually at last and 506 
refined with Refmac5 again to obtain the final model. The Mp1p-LBD1-LBD2 dataset at 507 
resolution 4.20Å was first solved using molecular replacement with closed apo-Mp1p-LBD1 508 
and apo-Mp1p-LBD2 structures as search models. The density map of single MR solution 509 
showed connectivity corresponding to previously unobserved linkers and revealed how the 510 
two Mp1p-LBD1 and the two Mp1p-LBD2 are connected. The cross density at the hinge 511 
point (Gly259) in Mp1p-LBD2 showed that the both Mp1p-LBD2 domains were in open 512 
conformation as in PDB 3L1N (Supplementary Figure.S1). After manual addition of the 513 
missing linkers and removal of unseen sidechains due to the relatively low resolution, 514 
refinements were performed with cycles of manual adjustment of model using Coot and 515 
Refmac5 in CCP4 package including global NCS restraints, jelly-body refinement and 516 
Prosmart to generate fragment constraints. The final models are checked with online program 517 
MolProbity (31). Data collection and refinement statistics are summarized in Table 1. The 518 
Ramachandran plots of the three final structures are shown in supplementary Figure 3. All the 519 
graphical presentations of these structures were prepared with graphical software PyMOL 520 
(http://www.pymol.org). 521 
 522 
Static-light scattering (SLS) to determine molecular weight of Mp1p-LBD1-LBD2 in 523 
solution 524 
SLS experiments were performed with the assistance from Dr. Y. Zhao’s group (The 525 
Hong Kong Polytechnic University, Hong Kong). Purified Mp1p-LBD1-LBD2 samples (with 526 
or without AA) were separated with S75 10/300 column (GE Healthcare) already equilibrated 527 
with filtered buffer 25mM Tris-HCl (pH 7.5) and 150mM NaCl at 298K. Protein peaks eluted 528 
from column were immediately measured with coupled SLS instrument DynaPro Nanostar 529 
(Wyatt) using estimated extinction coefficient 4470 M
-1
cm
-1
. The analysis of protein peaks 530 
were performed with the program DYNAMICS provided.   531 
 532 
Pull-down experiment on the cell lysate of J774 macrophage cells with Mp1p-LBD1 533 
The J774 murine macrophage cell line was grown in Dulbecco's Modified Eagle's 534 
Media (DMEM, Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum 535 
(FBS) at 37 °C. Lipopolysaccharide (LPS)-induced inflammatory response was achieved by 536 
stimulating the macrophage with 1 g/ml LPS at 37 °C for 24 h. The cells were harvested from 537 
confluent cultures and washed three times with 1X PBS buffer at 4 °C. Cell suspension in 1X 538 
PBS containing 3×10
6 
cells per tube were mixed respectively with 1000, 250 and 50 µg of 539 
soluble delipidated His-tagged Mp1p-LBD1 protein on ice. The mixture was immediately 540 
sonicated on ice for 20 sec, followed by incubation on ice for 30 min in the presence of 10 541 
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µg/ml complete protease inhibitor mixture (Roche Applied Science). Cell pellet was 542 
deposited after centrifuging at 10,000×g for 15 min. The supernatant layer was then 543 
incubated with 30 µl of Ni-NTA agarose resin (Qiagen) at 4 ºC for 30 min. The resin was 544 
washed with twenty column volumes of 1X PBS buffer supplemented with 10 mM 545 
imidazole. Lipid-bound His-tagged Mp1p-LBD1 protein was eluted with 200 µl of PBS 546 
buffer containing 200 mM imidazole. Bound-lipids in the Mp1p-LBD1 protein were 547 
extracted by incubating with organic solvent mixture (DIPE and n-butanol (3:2 v/v)) at 1:1 548 
ratio for 30 min at room temperature. The organic layer was separated by centrifugation (2 549 
min, 13000 rpm) and subjected to untargeted small molecule profiling by ultra-high-550 
performance liquid chromatography-electrospray ionization-quadruple time-of-flight mass 551 
spectrometry (UHPLC-ESI-QTOFMS) using lipid profiling method, to analyse lipid species 552 
as we have previously described (32, 33). Control pull-down experiments without adding 553 
Mp1p-LBD1 to LPS-induced J774 cells were performed under the same procedures. Three 554 
biological replicates were performed for each pull-down experiment, and triplicate 555 
measurements were made for each pull-down condition.  556 
 557 
Untargeted pull-down extract profiling using UHPLC-ESI-QTOFMS 558 
UHPLC-ESI-QTOFMS analysis was performed using M-class UHPLC (Waters, 559 
USA) coupled with a Synapt G2-Si HDMS spectrometer (Waters, USA) accompanied with a 560 
Masslynx software for QTOF (V 4.1, Waters, USA). Waters Acquity UPLC BEH C18 561 
column (2.1 × 100 mm, 1.7 μm) (Waters, Milford, MA, USA) was applied for the separation 562 
of a wide range of lipids with the injection volume of 8 μl. The column and auto-sampler 563 
temperature were kept at 45 °C and 10 °C, respectively. Mobile phase A was LC-MS grade 564 
water containing 0.1 % acetic acid (v/v) and mobile phase B was acetonitrile. LC separation 565 
was achieved at a flow rate of 0.4 ml/min by applying a gradient program as follows: t = 0 566 
min, 0.5 % B; t = 1.5 min, 0.5 % B; t = 8 min, 8 % B; t = 18 min, 35 % B; t = 25 min, 70 % 567 
B; t = 34 min, 99.5 % B; t = 36 min, 99.5 % B; t = 38.1 min, 0.5 % B. The total run time was 568 
40 min.  569 
 570 
MS Conditions 571 
Mode of Operation                         TOF MS
E
 572 
Ionization and Capillary voltage               ESI +ve (+3500 V) and –ve (-3500 V) 573 
Cone voltage                              20.0 V 574 
Collision energy                            20 V & Ramp 30-50 V 575 
Source temperature                              120 °C 576 
Desolvation temperature                          350 °C 577 
Desolvation gas                            500.0 L/Hr (N2) 578 
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Acquisition range                           60-1500 579 
Calibrant                                 Leucine Enkephalin 580 
 581 
Data Processing and statistical analysis. The LC-MS data was processed as described by 582 
Lau et al (2015) (34). Multi- and uni-variate statistical analyses were carried out to identify 583 
specific lipids in extraction samples that are present in significantly higher levels in pull 584 
down samples but not in the control samples. Only entries with at least 50 % frequency 585 
present in either one of pull-down sample or control groups were included for further 586 
statistical analysis to reduce noise. Volcano plots based on P < 0.01 combined with fold-587 
change (FC) analysis with FC > 2 were applied to highlight molecular features (MFs) with 588 
high abundance ratios between 2 groups. 589 
 590 
Lipid identification. MFs with significant abundance were selected for MS/MS experiment 591 
and analysis. The MS/MS data was processed using Waters MassLynx Analysis software 592 
(Version 4.1, Waters, USA) to generate list of potential molecular formula. All putative lipids 593 
were identified by using exact molecular weights, nitrogen rule, MS
2
 fragment and 594 
literature/database search (METLIN, Lipidmaps, etc.). Fatty acid moieties of identified LPCs 595 
were determined using fatty acid scanning (FAS) method as described by (12). 5 mM 596 
ammonium acetate was spiked into the pull-down lipid extract to yield anion adduct [M + 597 
CH3COO-, M + H+58]. FAS analysis was achieved by acquiring precursor ion spectra with 598 
selected fragment ions containing 16 to 20 carbon atoms and 0 to 4 double bonds under 599 
negative ion mode. Collision energy was ramping from 25 eV to 35 eV. 600 
 601 
NMR and isothermal titration calorimetry (ITC) data collection and processing. AA 602 
was titrated into a 
15
N-labeled delipidated sample of Mp1p-LBD1. Two-dimensional 
1
H-
15
N 603 
heteronuclear single quantum coherence (2D NHSQC) experiments were acquired at 299.1 K 604 
on a Bruker Avance 600 MHz NMR spectrometer (
1
H and 
15
N frequencies of 600.133 and 605 
60.818 MHz, respectively) equipped with a 5-mm BBI probe with Z-gradient using standard 606 
Bruker pulse sequences. Data were acquired and analyzed using Topspin 3.1 (Bruker). 607 
Chemical shifts are given on a ppm scale and coupling constants are reported in Hz. All 
1
H 608 
chemical shifts were referenced to trimethylsilylpropanoic acid methyl resonance at 0 ppm. 609 
Chemical shifts of 
15
N were referenced indirectly by gyromagnetic ratio method. Free 610 
induction decays were multiplied with an exponential line broadening function of 0.3 Hz 611 
before Fourier transformation. The sizes of F2 dimension were 2048 points and that of F1 612 
dimension was 256 points, which were Fourier-transformed into 2048 x 1024 points. Spectral 613 
widths were 9014.423 x 2736.807 Hz. Delipidated Mp1p-LBD1 protein samples (100 mM) 614 
were loaded into the sample cells and titrated with an AA stock solution of 10 mM by an 615 
iTC200 microcalorimeter (Ultrasensitive Calorimetry for the Life Science, MicroCal). The 616 
starting temperature was 37℃, and the reference in the reference cell was pure autoclaved 617 
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water. The titrations were performed by injecting 20 consecutive 5 ul aliquots of AA stock 618 
solution into the ITC cell containing the Mp1p-LBD1 sample. The titration experiment was 619 
performed in triplicate. The binding stoichiometry (n), binding affinity (Kd), enthalpy 620 
changes (H), and entropy (S) of the protein-ligand interaction were determined by 621 
analyzing the resulting ITC data with the software ORIGIN 7 using appropriate binding 622 
models. 623 
 624 
Accession codes: Mp1p-LBD1 in complex with co-purified PLM was deposited with PDB 625 
accession code 5E7X. Mp1p-LBD1 in complex with AA was deposited with PDB accession 626 
code 5ECF. Mp1p-LBD1-LBD2 was deposited with PDB accession code 5X3Q. 627 
 628 
  629 
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 752 
Table 1. Data collection and refinement statistics of X-ray structures (molecular 753 
replacement) 754 
 Mp1p-LBD1-PLM Mp1p-LBD1-AA Mp1p-LBD1-LBD2 
Data collection    
Space group P43 P21 P41212 
Cell dimensions    
a, b, c (Å) 52.58,52.58,57.69 65.68,104.27,108.10 146.36,146.39,148.61 
α,β,γ (º)  90.00, 90.00, 90.00 90.00, 97.44, 90.00 90.00, 90.00, 90.00 
Resolution (Å) 38.86-1.8 (1.85-
1.80)* 
107.19-2.60 (2.69-2.60) 50.00-4.20 (4.35-4.20) 
Rsym or Rmerge 0.027 (0.583) 0.074 (0.390) 0.153 (0.000) 
I / σI 22.7 (1.8) 12.6 (2.16) 9.520 (1.74) 
Completeness (%) 99.1 (95.6) 94.4 (69.7) 99.7 (100.0) 
Redundancy 3.7 (3.6) 3.6 (2.8) 6.2 (6.3) 
Refinement    
Resolution (Å) 45.00-1.45 (1.85-
1.80) 
107.19-2.60 (2.69-2.60) 50-4.20 (4.35-4.20) 
No. reflections 14575 44571 12286 
Rwork / Rfree 0.179/0.221 0.256/0.290 0.2943/0.3496 
No. atoms    
    Protein 1151 10929 3217 
    Ligands 18  88  N/A 
    Water 53 19 N/A 
B-factors    
    Protein 36.23 38.51 135.31 
    Ligands 44.55  32.20 N/A 
    Water 40.35 36.60 N/A 
R.M.S. deviations #    
    Bond lengths (Å) 0.0071 0.0169 0.0106 
    Bond angles (º) 1.1528 1.0730 1.2520 
MolProbity validation    
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MolProbity scores      
(percentile) 
0.84 (100th ) 
 
1.98 (97th) 1.96 (100th) 
Clashscores 
(percentile) 
1.24 (100th) 12.79 (93th)  12.87 (97th) 
 
Ramachandran 
favored/outliers(%) 
99.35/0 98.48/0.07 95.15/0.49 
*Values in parentheses are for highest resolution shells.  755 
#
 R.M.S deviations mean root-mean-square deviations. 756 
 757 
  758 
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Table 2. Cellular level of arachidonic acid (AA) in J774 cells in non-infected and infected 759 
with Mp1p knockout and wild-type strains of T. marneffei conditions. 760 
 Non-infected Mp1p knockout T. 
marneffei 
wild-type T. 
marneffei 
MS extract sample [AA] 
(nM)
a
 
583±36 550±30 470±20 
AA (pmole/1x10
6
 cells)
b
 35.0±2.2 33.0±1.8 28.2±0.9 
Cellular [AA] (µM)
 c
 3.50 3.30 2.82 
a
 AA concentration in 180 µl extraction buffer from cell lysate containing 3×10
6
 cells  761 
b
 Amount of AA in sample normalized to 1×10
6
 cells 762 
c
  Assuming a cellular volume of ~ 10 µl per 1x10
6
 J774 cells  763 
 764 
  765 
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Table 3. In vitro pull-down experiments with various amount of Mp1p-LBD1 against cell 766 
lysates of J774 macrophage cells: 767 
(A) Profile list of identified lipids from the organic layer extracted under different amount of 768 
Mp1p-LBD1 bait protein. 769 
Low  
Mp1p-LBD1 (50mg) 
Medium  
Mp1p-LBD1 (250mg) 
High  
Mp1p-LBD1 (1000mg) 
Arachidonic Acid  Arachidonic Acid  Arachidonic Acid  
Oleic Acid  Oleic Acid  Oleic Acid  
-  Palmitic Acid  Palmitic Acid  
-  LPC1, 482.3612  LPC1, 482.3612  
-  LPC2, 496.3413  LPC2, 496.3413  
-  -  LPC3, 522.3559  
-  -  LPC4, 524.2736  
*LPC= lysophosphatidylcholine 770 
(B) The identity of each LPC was not characterized. All LPC ions give rise to the same 771 
characteristic fragment ion (m/z = 184.0735) in high energy mode (Collision energy CE 772 
=30-50eV).  773 
PIS (M+H, 184.1) FAS
b
 
Remarks  
Precursor 
Ion 
Brutto 
Composition
a
 
Precursor 
Ion 
Fatty Acid 
Moieties 
496.4  16:0  554.5  16:0  Palmitoyl-LPC  
482.4  16:0  540.5  16:0  LPC(O-16:0), Lyso-PAFC16  
522.4  18:1  580.5  18:1  Oleoyl-LPC  
524.4  18:0  602.5  18:0  LPC(18:0)  
a 
Number of carbon: Number of double bond 774 
b 
Fatty acid scanning (35) = 255.2 (16:0), 281.2 (18:1), 283.2 (18:0) 775 
c 
Fatty acid moieties of identified LPCs were determined using fatty acid scanning (FAS) 776 
method as described by Ekroos et al (2003) (12) 777 
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*LPC= lysophosphatidylcholine; PAF=platelet-activating factor 778 
  779 
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Figure Captions 780 
Figure 1. Crystallographic structure of Mp1p-LBD1 in complex with co-purified PLM at 781 
1.80Å resolution. (A) Overall monomeric structure of Mp1p-LBD1 complexed with PLM 782 
(shown in cyan spheres). The length of this domain was about 47Å. (B) Alignments of this 783 
monomeric Mp1p-LBD1 structure (green) with two domain-swapped, open Mp1p-LBD2 784 
complexed with palmitic acid (PDB 3L1N, magenta and blue) (left, 762 main chain atoms 785 
with RMS = 0.668Å) and monomeric Mp1p-LBD2 complexed with arachidonic acid (PDB 786 
5CSD, red) (right, 811 main chain atoms with RMS = 0.538Å). The helix 3 of Mp1p-LBD1 787 
resembled the same helix in 5CSD, but not 3L1N (regions highlighted in orange boxes), in 788 
which helix 3 turns and breaks the continuation at conserved glycine residue (indicated by 789 
arrows in corresponding colours). (C) 2mFo-DFc map (green, contour level: 1.0σ) of PLM in 790 
refined model. (D) The amino acid residues involved in interaction between co-purified PLM 791 
and Mp1p-LBD1. 792 
 793 
Figure 2. Superposition of different Mp1p-LBD structures with different ligands positions 794 
revealed a possible reason of domain-swapping in Mp1p-LBD2 in crystal structures. (A) 795 
Alignment of helices 3 from Mp1p-LBD1 complexed with PLM (orange) and Mp1p-LBD2 796 
complexed with AA (5CSD, cyan) near the “hinge” regions. (B) Alignment of H3 helices 797 
from Mp1p-LBD1 complexed with PLM (orange) and LBD2 complexed with PLM (3L1N, 798 
green and purple for the helix 3 from another Mp1p-LBD2 monomer) near the “hinge” 799 
regions. The PLM in Mp1p-LBD1 and AA in Mp1p-LBD2 locate near the hinge points of 800 
both Mp1p-LBDs, providing additional hydrophobic interactions around this region which 801 
may stabilize the closed configuration during crystallization. PLM in Mp1p-LBD2, however, 802 
locates on the other side of the binding cavity, leading to the absence of the hydrophobic 803 
interaction and may lead to domain-swapped open structure as observed in 3L1N.  804 
 805 
Figure 3. Mp1p-LBD1 complexed with 1 or 2 AAs. (A) Overall closed monomeric structures 806 
of Mp1p-LBD1 complexed with 1 AA molecule (Left) and 2 AA molecules (Right). Bound 807 
AAs are shown in cyan spheres at the middle of the five-helical bundles. (B) 2mFo-DFc 808 
maps (green, contour level: 1.0σ) of AA in refined models. Top: singly-bound AA. Bottom: 809 
Two AAs in 2-AAs bound form. (C) Detailed interaction between AA and Mp1p-LBD1. Left 810 
panel: Singly-bound AA in Mp1p-LBD1-AA form. Middle panel: AAa in Mp1p-LBD1-2AA 811 
form. Ser165 also provides hydrogen bond. Right panel: AAb in Mp1p-LBD1-2AA on the 812 
other side of the cavity. 813 
 814 
Figure 4. Asn105 in Mp1p-LBD1 provides additional hydrogen bond to bind AA, leading to 815 
shifted AA positions compared to AAs in Mp1p-LBD2. (A) Superposition of Mp1p-LBD1-816 
1AA (pink) and Mp1p-LBD1-2AAs (green). AAa in Mp1p-LBD1-2AA superimposes the 817 
singly-bound AA. Asn105 is involved to form hydrogen bond with bound AA in both forms. 818 
(B)   Superposition of Mp1p-LBD1-1AA (pink) and Mp1p-LBD2-1AAs (orange). It is clear 819 
that the interlude of Asn105 preferentially forms hydrogen bond with singly-bound AA in 820 
Mp1p-LBD1, while the singly-bound AA in Mp1p-LBD2 penetrates deeper into the cavity 821 
and form hydrogen bond with the conserved glutamine residue (Gln298 in Mp1p-LBD2). (C) 822 
Superposition of Mp1p-LBD1-2AA (green) and Mp1p-LBD2-2AAs (Blue). The 823 
conformation of the 2 bound AAs are largely conserved in both Mp1p-LBDs, but the 824 
positions of the head groups differ due to additionally available hydrogen bond partner from 825 
Asn105 in Mp1p-LBD1. 826 
 827 
  828 
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Figure 5. Crystal structure of Mp1p-LBD1-LBD2 at 4.20Å resolution. (A) Pseudo-dimeric 829 
structure of Mp1p-LBD1-LBD2. Two monomers are colored in green and yellow, 830 
respectively. (B) Structure at Mp1p-LBD2 hinge point Gly259 of helix 3 (in full, shown in 831 
red) causing the open conformation of Mp1p-LBD2. This part is thus the same as the single 832 
domain Mp1p-LBD2-PLM structure (PDB 3L1N). (C) The two modelled linkers (shown in 833 
red) built between two pairs of Mp1p-LBD1 and Mp1p-LBD2. 834 
 835 
Figure 6. In vitro pull-down experiments with various amount of Mp1p-LBD1 against cell 836 
lysates of J774 macrophage cells. (A) Profile list of identified lipids from the organic layer 837 
extracted under different amount of Mp1p-LBD1 bait protein. (B) The identity of each LPC 838 
was not characterized. All LPC ions give rise to the same characteristic fragment ion (m/z = 839 
184.0735) in high energy mode (Collison energy CE =30-50eV). Fatty acid moieties of 840 
identified LPCs were determined using fatty acid scanning (FAS) method as described by 841 
Ekroos et al (2003) (12). 842 
 843 
Figure 7. NMR titration experiments of 15N-Mp1p-LBD1 with AA.1H-15N HSQC titration 844 
spectra of 15N-Mp1p-LBD1 in the absence (blue) and presence (red) of AA. Mp1p-LBD1 845 
was titrated against AA at pH 8.0. Most peaks displayed slow exchange (peak weakening) 846 
while some show fast exchange (peak shifting)  847 
 848 
Figure 8. Isothermal Titration Calorimetry (ITC) of AA binding to Mp1p-LBD1. (Top 849 
panels) Raw heats of binding obtained by ITC when AA was mixed with Mp1p-LBD1. 850 
(Bottom panels) Table of thermodynamic parameters obtained by fitting the ITC data to a 851 
two-site binding model (Kd = dissociation constant, ΔH = change in enthalpy, -TΔS = change 852 
in entropy, N = number of binding sites, subscript 1 and 2 refer to the 1st and 2nd binding 853 
step for data fit to a two-site model. 854 
 855 
 856 
 857 
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